Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid DKr68mn (£7.8mn) last year....
...“Having a broken leg didn’t make me a lesser person, but it did dictate my immediate actions and greatly limited my options in the moment,” the 57-year-old said on Tuesday....
...“Investments in life sciences are taking place in the US and, as a consequence, lots of the talent is based in the US.”...
...It already made its diagnostics products in the country but had “limited manufacturing for pharma”, he added....
...Under the commission’s proposed new pharma plans, which are still under discussion and have not yet become law, manufacturers would be required to market new drugs in all 27 EU countries within two years...
...“[This means] the return on investment for antibacterials is much lower than other types of drug development.”...
...“The company has been actively working together with its advisers to set the record straight and advocate for changes to the proposed legislation,” Edward Hu, vice-chair and chief investment officer, said...
...Regardless of the precise solution, venue should be limited to judicial districts with bona fide connections to the debtor....
...The approval of Madrigal’s drug should help other treatments to pass regulatory hurdles, according to analysts at investment bank William Blair....
...But don’t assume that these burgeoning product lines will be healthy investment options, nor that they are necessarily terribly sustainable. Read it here....
...“I’d put Vertex in my pharma top three [to invest in].” This year, Vertex’s market capitalisation surpassed $100bn for the first time....
...But leading shareholders welcomed the pay rise before the vote, with Rajiv Jain, chief investment officer at top-20 shareholder GQG Partners, saying Soriot was “massively underpaid” given the performance...
...Under the proposed reforms, Medicare, the US taxpayer-funded healthcare scheme for retirees, would be allowed to negotiate prices for a limited number of branded medicines....
...It will allow shareholders in participating companies to sell their stock on a limited number of days each year....
...The biotech group’s investors for this funding round include MSD GHIF, an investment arm of US pharma company MSD, along with UK venture capital group IQ Capital....
...However, Markus Manns, a portfolio manager at Germany’s third largest asset manager Union Investment, was more upbeat....
...Art is not an investment, but unfortunately investment is an art Someone from the art world or the money world, or both, is always making the case that art is an investment, not just an adornment....
...Return on investment Turkey’s President Recep Tayyip Erdoğan drove a hard bargain when negotiating a €6bn migration deal with the EU some eight years ago....
...Voya Investment Management has also hired Eric Stein as its head of investments and chief investment officer of fixed income. Stein joins from Morgan Stanley Investment Management....
...limited liability partnership....
...The pharma group’s investment-grade debt sale, which has not yet priced, will span eight or nine maturity brackets from two to 40 years....
...That push would provide a welcome boost for the biggest local biotech and pharma groups, including Jiangsu Hengrui, WuXi Biologics, Shanghai Fosun Pharma and Sinopharm....
...In recent years, the university town’s technology and life sciences industry scene has been attracting record investment, talent — and homebuyers....
...The pharma group said drugs developed by its legacy companies helped to form the “building blocks” of today’s GSK....
International Edition